Effects of CYP2C19 LoF allele on major adverse cardiovascular events associated with clopidogrel in acute coronary syndrome patients undergoing percutaneous coronary intervention: Meta-analysis
The aggregated risk of major adverse cardiovascular events (MACE) in acute coronary syndrome (ACS) patients inheriting CYP2C19 loss-of function (LoF) alleles who underwent percutaneous coronary intervention (PCI) and were treated with clopidogrel is controversial. In the current study, we searched t...
Saved in:
Main Authors: | Biswas, Mohitosh, Sukasem, Chonlaphat, Khatun Kali, Most Sumaiya, Ibrahim, Baharudin |
---|---|
Format: | Article |
Published: |
Future Medicine Ltd
2021
|
Subjects: | |
Online Access: | http://eprints.um.edu.my/35259/ |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effects of the CYP2C19 LoF allele on major adverse cardiovascular events associated with clopidogrel in acute coronary syndrome patients undergoing percutaneous coronary intervention: A meta-analysis
by: Biswas, Mohitosh, et al.
Published: (2021) -
A Study On Cyp2c19 Genetic Variations Of Clopidogrel And Ticagrelor Treatment Among Coronary Artery Disease (CAD) Patients Undergoing Percutaneous Coronary Intervention (PCI)
by: Ak-Kaif, Mohammed Ahmed Imran
Published: (2023) -
Young coronary artery disease in patients undergoing percutaneous coronary intervention
by: Zuhdi, A.S., et al.
Published: (2013) -
The impact of percutaneous coronary intervention (PCI) on diastolic dysfunction in coronary artery disease
by: Umar, Bello Tambuwal
Published: (2014) -
Neglected cardiovascular risk factors: Relationship of anxiety and depression with percutaneous coronary angioplasty
by: Hadi, Mohd Firdaus, et al.
Published: (2021)